Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000979819 | SCV001127766 | likely benign | not provided | 2024-01-20 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000979819 | SCV001784939 | likely benign | not provided | 2018-12-17 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000979819 | SCV005228207 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001832273 | SCV002093813 | likely benign | Usher syndrome type 1 | 2020-03-22 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004535995 | SCV004723657 | likely benign | CDH23-related disorder | 2020-12-15 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |